AUSTIN, Texas, May 29, 2025 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene (NYSE: CNC), has announced the latest recipients of its annual community and provider grant program. The $200,000 in funding is targeted to address the needs of low-income neighborhoods and communities across Texas.
"We're excited to announce the grant recipients for this year and are proud to support these community-based organizations and providers as they use this funding to make a meaningful impact in the lives of Texans," said Dr. Susan Mills, senior vice president of population health and clinical operations at Superior HealthPlan. "We sincerely value their commitment and look forward to working together."
Community Grant Winners
Organization | Region Served | Grant Purpose |
El Paso | Purchase diapers and wipes to expand diaper distribution program. | |
Wichita Falls | Replace exercise equipment for senior fitness program. | |
Lubbock | Purchase updated health and safety equipment needed to operate 5 early learning centers. | |
Austin | Create community walking trail. | |
Waco | Expand food distribution network. | |
Dallas | Develop and implement independent living skills curriculum for people with disabilities. | |
Sherman | Expand diaper distribution program. | |
San Antonio | Support 4 family events to address key non-medical drivers of health. | |
McAllen | Provide summer safety, financial literacy, and conservation workshops for community. | |
Corpus Christi | Expand nutrition program by increasing meal delivery services for elderly individuals. |
Provider Grant Winners
Organization | Region Served | Grant Purpose |
El Paso | Provide continuing education and training opportunities to advance | |
Wichita Falls | Purchase assistive tools to help keep seniors upright and moving. | |
Lubbock | Acquire 3 diabetic retinopathy screening instruments to identify those at risk. | |
Austin | Purchase handheld digital retinal camera, increasing capacity | |
Killeen | Purchase a screening tool to check vision abnormalities as early as 6 months of age. | |
Dallas | Replace vaccine storage refrigerator and freezer to ensure safety and prevent loss. | |
Sherman | Provide medically fragile members with "go-bags" full of personal | |
San Antonio | Fund a Saturday wellness clinic to offer incentives for patients to get | |
McAllen | Expand indoor and outdoor fitness areas to encourage physical activity. | |
Corpus Christi | Develop interactive tools and educational materials for the waiting area |
Since 2020, Superior has provided more than $940,000 in funding to hundreds of community partners and providers through its grant program, which addresses non-medical drivers of health, such as access to food, economic stability, health care, housing, education, and other critical needs that affect overall health and well-being.
To learn more about the grant program, visit SuperiorHealthPlan.com/grants.
About Superior HealthPlan
For more than 25 years, Superior HealthPlan has offered high-quality health care to Texans, and is now a leading managed care company providing services to 2 million people. Committed to transforming the health of the communities we serve, one person at a time, Superior supports active local involvement in all 254 Texas counties with 3,500 employees throughout the state. Since 2020, Superior has contributed $11.9 million in grants, sponsorships and employee giving, helping support low-income communities. Superior is a company of Centene, a leading healthcare enterprise that is committed to helping people live healthier lives. For more information, visit www.SuperiorHealthPlan.com.
| Last Trade: | US$36.82 |
| Daily Change: | 1.08 3.02 |
| Daily Volume: | 9,529,813 |
| Market Cap: | US$18.080B |
July 29, 2025 July 25, 2025 April 25, 2025 February 24, 2025 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
